Correlations of sleep disturbance with the immune system in type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 85, Issue 3, 2009, Pages 286-292

  Tsujimura, Takahiro ^a,b   Matsuo, Yoshinobu ^a,b   Keyaki, Takahiro ^b   Sakurada, Kumi ^a   Imanishi, Jiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Clinic Grandsoul Nara   (Japan)

Author keywords

Actigraph; Circadian rhythm; Immunity; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; CYTOKINE; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

ACTIMETRY; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL ACTIVITY; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; GLUCOSE BLOOD LEVEL; HELPER CELL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOLOGICAL PARAMETERS; IMMUNOSTIMULATION; MALE; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS;

ACTIVITIES OF DAILY LIVING; ACTIVITY CYCLES; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNE SYSTEM; MALE; MIDDLE AGED; REFERENCE VALUES; SLEEP DISORDERS; WAKEFULNESS;

EID: 68249112133     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.07.001     Document Type: Article

References (25)

1. Yaggi H.K., Araujo A.B., and McKinlay J.B. Sleep duration as a risk factor for the development of type 2 diabetes. Diabet. Care 29 (2006) 657-661
2. Mallon L., Broman J.-E., and Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration - a 12-year follow-up study a middle-aged population. Diabet. Care 28 (2005) 2762-2767
3. Kawakami N., Takatsuka N., and Shimizu H. Sleep disturbance and onset of type 2 diabetes. Diabet. Care 27 (2004) 282-283
4. Martins R.C., Andersen M.L., and Tufik S. The reciprocal interaction between sleep and type 2 diabetes mellitus: facts and perspectives. Braz. J. Med. Biol. Res. 41 (2008) 180-187
5. Beihl D.A., Liese A.D., and Haffner S.M. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Ann. Epidemiol. 19 (2009) 351-357
6. Chaput J.P., Despres J.P., Bouchard C., Astrup A., and Tremblay A. Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med. (2009) doi:10.1016/j.sleep.2008.09.016
7. Knutson K.L., Ryden A.M., Mander B.A., and Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabtes mellitus. Arch. Intern. Med. 166 (2006) 1768-1774
8. VanHelder T., Symons J.D., and Radomsky M.W. Effects of sleep deprivation and exercise on glucose tolerance. Aviat. Space Environ. Med. 64 (1993) 487-492
9. Tasali E., Leproult R., Ehrmann D.A., and Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 1044-1049
10. Spiegel K., Tasali E., Penev P., and Van Cauter E. Sleep curtailment in healthy young me is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann. Intern. Med. 141 (2004) 846-850
11. Taheri S., Lin L., Austin D., Young T., and Mignot E. Short duration is associated with reduced leptin, elevated ghrelin, and increase body mass index. PLoS Med. 1 (2004) 210-217
12. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
13. Spiegel K., Knutson K., Leproult R., Tasali E., and Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J. Appl. Physiol. 99 (2005) 2008-2019
14. Dworacka M., Winiarska H., Borowska M., Abramczyk M., Bobkiewicz-Kozlowska T., and Dworacki G. Pro-atherogenic alterations in T-lymphocyte subpopulations related to acute hyperglycaemia in type 2 diabetic patients. Circ. J. 71 (2007) 962-967
15. Sumida S. T-lymphocyte subsets in human non-insulin-dependent diabetes mellitus (type II) studied by two-color flow cytometry. Kurume Med. J. 38 (1991) 203-209
16. Tsiavou A., Hatziagelaki E., Chaidaroglou A., Koniavitou K., Degiannis D., and Raptis S.A. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 31 (2005) 135-141
17. Tsiavou A., Degiannis D., Hatziagelaki E., Koniavitou K., and Raptis S.A. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J. IFN Cytokine Res. 24 (2004) 381-387
18. Fernandez-Real J.M., and Pickup J.C. Innate immunity, insulin resistance and type 2 diabetes. Trends Endocrinol. Metabol. 19 (2007) 10-16
19. Redwine L., Hauger R.L., Gillin C., and Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels. J. Clin. Endocrinol. Metabol. 85 (2000) 3597-3603
20. Savard J., Laroche L., Simard S., Ivers H., and Morin C.M. Chronic insomnia and immune functioning. Psychosomat. Med. 65 (2003) 211-221
21. World Health Organization, WHO Expert Committee on Diabetes Mellitus, Second Report, Geneva, World Health Org, 1981 (Tech. Rep. Ser., no 646).
22. Kripke D.F., Mullaney D.J., Messin S., and Wyborney V. Wrist actigraphic measures of sleep and rhythms. Electroencephalogr. Clin. Neurophysiol. 44 (1978) 674-676
23. Taphoorn M.J., van Someren E., Snoek F.J., Strijers R.L., Swaab D.F., Visscher F., et al. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J. Neurol. 240 (1993) 446-448
24. Lichtenfels R., Biddison W.E., Schlz H., Vogt A.B., and Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods 172 (1994) 227-239
25. Chen R., Lowe L., Wilson J.D., Crowther E., Tzeggai K., Bishop J.E., et al. Simultaneous quantification of six human cytokines in a single sample using microparticle-based flow cytometric technology. Clin. Chem. 45 (1999) 1693-1694